Abstract Background Renal cell carcinomas (RCC) are characterized by the deregulation of several hundred hyperosmolality-responsive genes. High expression of a subset of these genes including the Ran binding protein 3 like (RANBP3L) is linked to a favorable prognostic outcome in RCC. However, the cellular function of RANBP3L remains largely unknown. Methods We used CRISPR/Cas9-mediated gene editing to generate functional deletions of the Ranbp3l and nuclear factor of activated T cells 5 (Nfat5) gene loci in a murine renal cell line. The NFAT5-KO cells were used to assess the regulation of Ranbp3l by NFAT5 using immunofluorescence, RNA-Seq and promoter assays. RANBP3L-deficient cells were analyzed for changes in cell morphology, proliferatio...
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Characterization of RCC...
Here we presented that the expression of RUNX3 was significantly decreased in 75 cases of clear cell...
Abstract Background Advanced renal cell carcinoma (RCC) is therapeutically challenging. RCC progress...
RUNX3 (runt-related transcription factor-3) is a known tumor suppressor gene which exhibits potent a...
Chromosome region maintenance 1-mediated nucleocytoplasmic transport has been shown as a potential a...
The recurring association of specific genetic lesions with particular types of cancer is a fascinati...
Aim: Ran binding protein M (RanBPM) is a ubiquitous, nucleocytoplasmic protein that serves as a scaf...
Aim: Ran binding protein M (RanBPM) is a ubiquitous, nucleocytoplasmic protein that serves as a scaf...
Abnormal subcellular localization of proteins is an important cause of tumorigenesis and drug resist...
Background/Aim: Ran binding protein microtubule-organizing centre (RanBPM), also known as RanBP9, is...
Background/Aim: Ran binding protein microtubule-organizing centre (RanBPM), also known as RanBP9, is...
Genetic changes underlying clear cell renal cell carcinoma(ccRCC) include alterations in genes contr...
The osmosensitive transcription factor nuclear factor of activated T-cells (NEAT) 5, also known as t...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. The purpose of...
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Characterization of RCC...
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Characterization of RCC...
Here we presented that the expression of RUNX3 was significantly decreased in 75 cases of clear cell...
Abstract Background Advanced renal cell carcinoma (RCC) is therapeutically challenging. RCC progress...
RUNX3 (runt-related transcription factor-3) is a known tumor suppressor gene which exhibits potent a...
Chromosome region maintenance 1-mediated nucleocytoplasmic transport has been shown as a potential a...
The recurring association of specific genetic lesions with particular types of cancer is a fascinati...
Aim: Ran binding protein M (RanBPM) is a ubiquitous, nucleocytoplasmic protein that serves as a scaf...
Aim: Ran binding protein M (RanBPM) is a ubiquitous, nucleocytoplasmic protein that serves as a scaf...
Abnormal subcellular localization of proteins is an important cause of tumorigenesis and drug resist...
Background/Aim: Ran binding protein microtubule-organizing centre (RanBPM), also known as RanBP9, is...
Background/Aim: Ran binding protein microtubule-organizing centre (RanBPM), also known as RanBP9, is...
Genetic changes underlying clear cell renal cell carcinoma(ccRCC) include alterations in genes contr...
The osmosensitive transcription factor nuclear factor of activated T-cells (NEAT) 5, also known as t...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. The purpose of...
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Characterization of RCC...
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Characterization of RCC...
Here we presented that the expression of RUNX3 was significantly decreased in 75 cases of clear cell...
Abstract Background Advanced renal cell carcinoma (RCC) is therapeutically challenging. RCC progress...